Charakterystyka defektywnych szczepow MRSA nie wytwarzajacych koagulazy lub czynnika CF

• Autorzy: Garbacz K. , Piechowicz L. , Wisniewska K. , Galinski J.
• Języki publikacji: PL

Abstrakty

PL

Przebadano 186 szczepów MRSA pochodzących z różnych ośrodków regionu gdańskiego. Określono obecność genów nuc, mec A i coa metodą PCR. Wykryto 14 szczepów defektywnych, które nie wytwarzały koagulazy (7,25%) oraz 7 szczepów nie posiadających czynnika CF (3,76%). W celu scharakteryzowania szczepów defektywnych określono ich wzory restrykcyjne genu koagulazy (coa) metodą PCR-RFLP oraz wzór fagowy i lekooporność. Wzór restrykcyjny B był charakterystyczny dla koagulazoujemnych MRSA, podczas gdy wzór A był bardziej rozpowszechniony i występował zarówno wśród CF-ujemnych jak i CF-dodatnich MRSA.

EN

The aim of the study was to estimate frequency of coagulase-negative and CF-negative strains among methicillin-resistant Staphylococcus aureus (MRSA) and to assess their homogcnicity in respect of genotype, fagotype and drug resistance pattern. A total of 186 MRSA strains collected from different hospitals in Gdańsk region were studied. Gens: nuc, mecA, and coa were identified by PCR method. The coagulase tube test for staphylocoagulase and the slide test for clumping factor were used. Coagulase - negative and CF - negative MRSA strains were confirmed by PCR - RFLP method of coa gene; phage typing and drug resistance pattern were evaluated by disc diffusion test. The results of the study showed low frequency of both coagulase - negative and CF-negative MRSA strains (7,25% and 3,76% respectively). Among MRSA population tested the simultaneous occurrence of the strains lacking coagulase and clumping factor was not observed. All coagulase negative MRSA had coagulase gene (coa) and differed from CF-negative strains in respect of coa gene.

Słowa kluczowe

PL

lekoopornosc; gen coa; szczepy bakteryjne; mikrobiologia lekarska; gen mec A; koagulaza; lancuchowa reakcja polimerazy; zakazenia szpitalne; gen nuc; Staphylococcus aureus

• Wydawca: -
• Czasopismo: Medycyna Doświadczalna i Mikrobiologia
• Rocznik: 2002
• Tom: 54
• Numer: 1
• Strony: 1-8
• Opis fizyczny: s.1-8,tab.,bibliogr.

Twórcy

autor

Garbacz K.

• Akademia Medyczna, Gdansk

autor

Piechowicz L.

autor

Wisniewska K.

autor

Galinski J.

Bibliografia

• 1. Ayliffe GAJ. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 24: S74-9.
• 2. Barski P, Piechowicz L, Galiński J, Kur J. Rapid assay for detection of methicillin-resistant Staphylococcus aureus using multiplex PCR. Molec Cellul Probs 1996; 10: 471-75.
• 3. Bergey's Manual of Systematic Bacteriology (edited by) Holt JG, Murray RGE, Brenner DJ, Bryant MP, Krieg NR, Moulder JW, Pfenning N, Sneath PHA, . Williams & Wilkins, Baltimore, 1986; 1016-17.
• 4. Blair JE, Williams REO. Phage typing of Staphylococci. WHO Biulletin 1961; 24: 771-78.
• 5. Courvalin P, Soussy CJ. Raport of the Comité de l'Antibiogramme de la Societé Francaise de Microbiologie. Clinical Microbiology and Infection. 1996; Vol. 2. suppl. 1: 46-49.
• 6. Finlay J, Miller L, Poupar J. Interpretative criteria for testing susceptibility of Staphylococci to Mupirocin. Antimicrob Agents Chemother 1997; 41: 1137-39.
• 7. Forsgren A. Significance of protein A production by staphylococci. Infect Immun. 1970; 2: 672-73.
• 8. Goh SH, Byrne K, Zhang L, Chow W. Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol 1992; 30: 1642-45.
• 9. Guzman CA, Guardati MC, Fenoglio D i inni. Novel immunoenzymatic assay for identification of coagulase-and protein A-negative Staphylococcus aureus strains. 1992; 30: 1994-97.
• 10. Kloos W.E, Lambe D.W. Staphylococcus, Manual of clinical microbiology,5th ed. American Society for Microbiology, Washington, D.C. 1991; 222-37.
• 11. Lee VTP, Goh SH, Byrne SK, Vortel J. Analysis of the coagulase gene by polymerase chain reaction as an epidemiology typing method of Staphylococcus aureus. Zbl Bakteriol 1992; suppl. 26.
• 12. Lindmark R, Movitz J, Sjoquist J. Extracellular protein A from a methicillin resistant Staphylococcus aureus. Eur J Biochem 1977; 74: 623-28.
• 13. Młynarczyk A, Młynarczyk G, Jeliaszewicz J. The genome of Staphylococcus aureus : review. Zbl Bakteriol 1998; 287: 277-314.
• 14. NCCLS: National Comittee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. 1994; 3rd ed.
• 15. NCCLS: National Comittee for Clinical Laboratory Standards. 1997; Vol. 17, No. 1; Doc. M100-S7, Tab. 2.
• 16. Neville LO, Billington OJ, Kibbler CC, Gillespie SH. Methicillin resistant Staphylococcus aureus without clumping factor, protein A and DNase. Lancet 1991; 338: 518 (Letter).
• 17. Schwarzkopf A, Schmidt-Rotte H, Schmidt H i inni. Molecular analysis of nosocomial infection by oxacillin-resistant Staphylococcus aureus lacking protein A and clumping factor. Lancet. 1992; 340: 621 (Letter).
• 18. Szymanowska A, Sawicka-Grzelak A, Młynarczyk A, Młynarczyk G. Evaluation of the drug-sensivity and biochemical properties of coagulase-negative S. aureus strains isolated from clinical speciment. Med. Dośw Mikrobiol. 1993; 45: 11-14.
• 19. Vandenesch F, Lebeau C, Bes M i inni. Coagulase deficiency in clinical isolates of Staphylococcus aureus involves both transcriptional and post-transcriptional defects. J Med Microbiol 1994; 40: 344-49.
• 20. Wanger AR, Morris SL, Ericsson C i inni. Latex agglutination-negative methicillin-resistant Staphylococcus aureus recovered from neonates: epidemiologic features and comparisonof typing methods. J Clin Microbiol. 1992; 30: 2583-88.